Teva Pharma (TEVA) Misses Q2 EPS by 4c, Lowers FY EPS Guidance, Cuts Dividend

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. GNK
3. NVDA
4. PLUR
5. AZN
6. SPCX
7. FNGR
8. USO
9. MOS
10. TSLA

Go back to Teva Pharma (TEVA) Misses Q2 EPS by 4c, Lowers FY EPS Guidance, Cuts Dividend

Teva Reports Second Quarter 2017 Financial Results

August 3, 2017 6:30 AM EDT

Revenues of $5.7 billion GAAP EPS loss of $5.94 Non-GAAP EPS of $1.02 2017 business outlook revised to non-GAAP EPS of $4.30 - $4.50 Teva announces second quarter 2017 dividend of 8.5 cents,
down 75% from 34 cents in the first quarter of 2017

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA) today reported results for the quarter ended June 30, 2017.

Second quarter results were lower than we anticipated due to... More